DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
AZD5099
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD5099
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HE3235
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor modulator
HE3235
×
Maximum Phase:
1
First Approval:
None
UNII:
891O182ZP5
Molecule Type:
Small molecule
Molecular Formula:
C21H32O2
Molecular Weight:
316.49
AlogP:
3.75
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
OLEANDRIN
1
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms
Unknown
OLEANDRIN
×
Maximum Phase:
1
First Approval:
None
UNII:
II95UDU7I4
Molecule Type:
Small molecule
Molecular Formula:
C32H48O9
Molecular Weight:
576.73
AlogP:
3.68
PSA:
120.75
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ARQ-621
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ARQ-621
×
Maximum Phase:
1
First Approval:
None
UNII:
UU55190C8S
Molecule Type:
Small molecule
Molecular Formula:
C28H24Cl2FN5O2
Molecular Weight:
552.44
AlogP:
5.27
PSA:
93.25
HBD:
2.0
HBA:
#RotB:
9.0
Source:
HYPERICIN
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell; Photochemotherapy; Psoriasis; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides
Unknown
HYPERICIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7V2F1075HD
Molecule Type:
Small molecule
Molecular Formula:
C30H16O8
Molecular Weight:
504.45
AlogP:
5.08
PSA:
155.52
HBD:
6.0
HBA:
#RotB:
0.0
Source:
BMS-394136
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-394136
×
Maximum Phase:
1
First Approval:
None
UNII:
M694U7167K
Molecule Type:
Small molecule
Molecular Formula:
C24H21Cl2FN4O
Molecular Weight:
471.36
AlogP:
5.98
PSA:
50.16
HBD:
1.0
HBA:
#RotB:
3.0
Source:
VINPOCETINE
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Diabetic Nephropathies; Attention Deficit Disorder with Hyperactivity
Unknown
VINPOCETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
543512OBTC
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O2
Molecular Weight:
350.46
AlogP:
4.15
PSA:
34.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SENEXIN B
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
SENEXIN B
×
Maximum Phase:
1
First Approval:
None
UNII:
E2X758P2BZ
Molecule Type:
Small molecule
Molecular Formula:
C27H26N6O
Molecular Weight:
450.55
AlogP:
3.7
PSA:
85.15
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SERDEMETAN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SERDEMETAN
×
Maximum Phase:
1
First Approval:
None
UNII:
ID6YB4W3V8
Molecule Type:
Small molecule
Molecular Formula:
C21H20N4
Molecular Weight:
328.42
AlogP:
4.96
PSA:
52.74
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PYRUVATE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis; Severe Acute Respiratory Syndrome
Unknown
PYRUVATE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
POD38AIF08
Molecule Type:
Small molecule
Molecular Formula:
C3H3NaO3
Molecular Weight:
110.04
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
HYODEOXYCHOLIC_ACID
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
LXR-alpha agonist
HYODEOXYCHOLIC_ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
7A33Y6EHYK
Molecule Type:
Small molecule
Molecular Formula:
C24H40O4
Molecular Weight:
392.58
AlogP:
4.48
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
4.0
Source:
NEDISERTIB
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Gliosarcoma; Leiomyosarcoma; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Neoplasms; Neuroendocrine Tumors; Prostatic Neoplasms; Rectal Neoplasms; Sarcoma; Small Cell Lung Carcinoma
Unknown
NEDISERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
GN429E725A
Molecule Type:
Small molecule
Molecular Formula:
C24H21ClFN5O3
Molecular Weight:
481.92
AlogP:
3.81
PSA:
93.49
HBD:
1.0
HBA:
#RotB:
5.0
Source:
KW-2478
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma
Unknown
KW-2478
×
Maximum Phase:
1
First Approval:
None
UNII:
E628ZH6U2C
Molecule Type:
Small molecule
Molecular Formula:
C30H42N2O9
Molecular Weight:
574.67
AlogP:
2.27
PSA:
127.23
HBD:
2.0
HBA:
#RotB:
16.0
Source:
URAPIDIL HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Aortic Dissection
Unknown
URAPIDIL HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
PVU92PZO12
Molecule Type:
Small molecule
Molecular Formula:
C20H30ClN5O3
Molecular Weight:
423.95
AlogP:
0.72
PSA:
71.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
RALANITEN ACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RALANITEN ACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
L10K286T2H
Molecule Type:
Small molecule
Molecular Formula:
C27H33ClO8
Molecular Weight:
521.01
AlogP:
4.44
PSA:
97.36
HBD:
0.0
HBA:
#RotB:
13.0
Source:
NORCANTHARIDIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
NORCANTHARIDIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8452E71EO7
Molecule Type:
Small molecule
Molecular Formula:
C8H8O4
Molecular Weight:
168.15
AlogP:
-0.14
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
0.0
Source:
REBASTINIB
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms
Tyrosine-protein kinase ABL inhibitor
REBASTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
75017Q6I97
Molecule Type:
Small molecule
Molecular Formula:
C30H28FN7O3
Molecular Weight:
553.6
AlogP:
6.05
PSA:
123.06
HBD:
3.0
HBA:
#RotB:
6.0
Source:
AZD-5438
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
AZD-5438
×
Maximum Phase:
1
First Approval:
None
UNII:
276Z913G29
Molecule Type:
Small molecule
Molecular Formula:
C18H21N5O2S
Molecular Weight:
371.47
AlogP:
3.38
PSA:
89.77
HBD:
1.0
HBA:
#RotB:
5.0
Source:
INCB-057643
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
INCB-057643
×
Maximum Phase:
1
First Approval:
None
UNII:
87TZD0JEBS
Molecule Type:
Small molecule
Molecular Formula:
C20H21N3O5S
Molecular Weight:
415.47
AlogP:
2.07
PSA:
101.47
HBD:
1.0
HBA:
#RotB:
2.0
Source:
INDIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms
Tubulin inhibitor
INDIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
80K4H2RB8P
Molecule Type:
Small molecule
Molecular Formula:
C22H16ClN3O2
Molecular Weight:
389.84
AlogP:
4.56
PSA:
63.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PLX8394
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PLX8394
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CT-7001
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Breast Neoplasms
Unknown
CT-7001
×
Maximum Phase:
1
First Approval:
None
UNII:
46D4HS9ODA
Molecule Type:
Small molecule
Molecular Formula:
C22H30N6O
Molecular Weight:
394.52
AlogP:
2.85
PSA:
86.51
HBD:
4.0
HBA:
#RotB:
7.0
Source:
CESIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CESIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
1KSV9V4Y4I
Molecule Type:
Small molecule
Molecular Formula:
Cs
Molecular Weight:
132.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SU-9516
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cyclin-dependent kinase 2 inhibitor
SU-9516
×
Maximum Phase:
1
First Approval:
None
UNII:
FD2SWT2SDI
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O2
Molecular Weight:
241.25
AlogP:
1.91
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LY03005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LY03005
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RIMEPORIDE
1
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne
Unknown
RIMEPORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
QH6B4V5743
Molecule Type:
Small molecule
Molecular Formula:
C11H15N3O5S2
Molecular Weight:
333.39
AlogP:
-0.57
PSA:
147.25
HBD:
3.0
HBA:
#RotB:
3.0
Source:
TIGILANOL TIGLATE
1
Small molecule
Investigational
Unknown
Unknown
Head and Neck Neoplasms; Melanoma; Sarcoma
Protein kinase C (PKC) activator
TIGILANOL TIGLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
R1ZJT87990
Molecule Type:
Small molecule
Molecular Formula:
C30H42O10
Molecular Weight:
562.66
AlogP:
1.23
PSA:
163.12
HBD:
4.0
HBA:
#RotB:
6.0
Source:
PF-05241328
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-05241328
×
Maximum Phase:
1
First Approval:
None
UNII:
8RAL5N48VT
Molecule Type:
Small molecule
Molecular Formula:
C19H21ClN4O4S
Molecular Weight:
436.92
AlogP:
3.11
PSA:
103.18
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TROTABRESIB
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Lymphoma, Non-Hodgkin; Neoplasms
Unknown
TROTABRESIB
×
Maximum Phase:
1
First Approval:
None
UNII:
K424WH3WU0
Molecule Type:
Small molecule
Molecular Formula:
C21H21NO4S
Molecular Weight:
383.47
AlogP:
3.4
PSA:
65.37
HBD:
0.0
HBA:
#RotB:
5.0
Source:
AZD6280
1
Small molecule
Investigational
Unknown
Unknown
Anxiety
GABA receptor alpha-2 subunit positive allosteric modulator
AZD6280
×
Maximum Phase:
1
First Approval:
None
UNII:
B9Z1OEH19D
Molecule Type:
Small molecule
Molecular Formula:
C20H22N4O3
Molecular Weight:
366.42
AlogP:
3.04
PSA:
99.36
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BMS-986158
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-986158
×
Maximum Phase:
1
First Approval:
None
UNII:
X8BW0MQ5PI
Molecule Type:
Small molecule
Molecular Formula:
C30H33N5O2
Molecular Weight:
495.63
AlogP:
5.54
PSA:
77.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LIFIRAFENIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase B-raf inhibitor
LIFIRAFENIB
×
Maximum Phase:
1
First Approval:
None
UNII:
8762XZS5ZF
Molecule Type:
Small molecule
Molecular Formula:
C25H17F3N4O3
Molecular Weight:
478.43
AlogP:
5.3
PSA:
89.13
HBD:
2.0
HBA:
#RotB:
3.0
Source:
POLYGLYCONATE
1
Small molecule
Investigational
Unknown
Unknown
Influenza, Human
Unknown
POLYGLYCONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
KOF6AD0GWS
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04776548
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
PF-04776548
×
Maximum Phase:
1
First Approval:
None
UNII:
CBR15S3HNJ
Molecule Type:
Small molecule
Molecular Formula:
C18H16FN3O3
Molecular Weight:
341.34
AlogP:
2.62
PSA:
67.59
HBD:
1.0
HBA:
#RotB:
3.0
Source:
R-306465
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
R-306465
×
Maximum Phase:
1
First Approval:
None
UNII:
5WD7KK1IIQ
Molecule Type:
Small molecule
Molecular Formula:
C19H19N5O4S
Molecular Weight:
413.46
AlogP:
1.26
PSA:
115.73
HBD:
2.0
HBA:
#RotB:
4.0
Source:
1
2
…
81
82
83
84
85
86
87
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA